EvolveImmune Targets Lymphoma With Novel T-Cell Engagers Harnessing CD2

 
• By Ayisha Sharma
  
Emerging Company Profile: EvolveImmune Therapeutics
The EVOLVE Platform Is Designed To Address T-Cell Exhaustion • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Emerging Company Profiles

More from Start-Ups & SMEs